Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Danese

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Gynaecological Oncology|January 1, 1991
Pelvic mass biopsy by operative transvaginal sonography (OTVS)E Volpi, P Zola, T de Grandis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2005
Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammationS Danese, S Semeraro, M Marini, et al.
Gut|September 13, 2003
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patientsS Danese, J A Katz, S Saibeni, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2009
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseasesH Szabò, G Fiorino, A Spinelli, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Platelets: new players in the mucosal scenario of inflammatory bowel diseaseS Danese, F Scaldaferri, A Papa, et al.
Contemporary Clinical Trials|November 22, 2011
Methylene blue MMX tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteersA Repici, A F D Di Stefano, M M Radicioni, et al.
Current Medicinal Chemistry|April 1, 2010
New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gutG Fiorino, W Fries, S A De La Rue, et al.
The American Journal of Gastroenterology|September 28, 2004
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseasesS Saibeni, B Bottasso, L Spina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2008
Endoclipping for gastric perforation secondary to second session of EMRC in locally residual early gastric cancer: a case reportG De Caro, N Pagano, A Malesci, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 1, 2019
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's diseaseP G Kotze, A Spinelli, J Warusavitarne, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Gynaecological Oncology|January 1, 1991
Pelvic mass biopsy by operative transvaginal sonography (OTVS)E Volpi, P Zola, T de Grandis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2005
Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammationS Danese, S Semeraro, M Marini, et al.
Gut|September 13, 2003
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patientsS Danese, J A Katz, S Saibeni, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2009
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseasesH Szabò, G Fiorino, A Spinelli, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Platelets: new players in the mucosal scenario of inflammatory bowel diseaseS Danese, F Scaldaferri, A Papa, et al.
Contemporary Clinical Trials|November 22, 2011
Methylene blue MMX tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteersA Repici, A F D Di Stefano, M M Radicioni, et al.
Current Medicinal Chemistry|April 1, 2010
New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gutG Fiorino, W Fries, S A De La Rue, et al.
The American Journal of Gastroenterology|September 28, 2004
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseasesS Saibeni, B Bottasso, L Spina, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2008
Endoclipping for gastric perforation secondary to second session of EMRC in locally residual early gastric cancer: a case reportG De Caro, N Pagano, A Malesci, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 1, 2019
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's diseaseP G Kotze, A Spinelli, J Warusavitarne, et al.
Pageof 9